Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices 55905 

Day 3 

Convening at 9 a.m. 

• Discussion of Current Business 

(continued). 

C. Public Presentations 

Only individuals who register and 

submit written testimony as specified in 

section IV. of this notice will be 

considered registered presenters. The 

time allotted for each presentation will 

be approximately 5 minutes but will be 

based on the number of registered 

presenters. Presenters will speak in their 

assigned order. If registered presenters 

are not given an opportunity to speak 

because of time restrictions, we will 

accept and present their testimony to 

the TAG members. Comments from 

other participants (individuals who are 

not registered presenters) may be heard 

after the scheduled testimonies, if time 

permits. 

If there are individuals who cannot 

attend the meeting but wish to submit 

comments/statements regarding 

emergency medical services or specialty 

hospitals, we will accept and present 

their written comments/statements at 

the meeting if their comments/ 

statements are received via postal mail 

or email at the address listed in the 

ADDRESSES section of this notice by 

October 12, 2005. 

III. Registration Instructions 

The Center for Medicare Management 

is coordinating meeting registration. 

While there is no registration fee, all 

individuals must register to attend due 

to limited seating. As specified in the 

DATES section of this notice, individuals 

who wish to attend the meeting but do 

not plan to present testimony must 

register by October 19, 2005. Individuals 

who would like both to attend and to 

present testimony on the topics of 

emergency medical services or specialty 

hospitals must register by October 5, 

2005 and must state specifically in their 

registration request that they wish to 

present testimony for EMTALA TAG 

consideration. A copy of the presenter’s 

written testimony must be received by 

CMS at the address specified in the 

ADDRESSES section of this notice by 

October 12, 2005. 

You may register with Marianne 

Myers at Marianne.Myers@cms.hhs.gov 

or by, fax to the attention of Marianne 

Myers at (410) 786–0681, or by 

telephone at (410) 786–5962. All 

registration requests must include your 

name, name of the organization (if 

applicable), address, telephone and fax 

numbers, e-mail address (if available). 

You will receive a registration 

confirmation with instructions for your 

arrival at the CMS Headquarters. If 

seating has been reached, you will be 

notified that the meeting has reached 

capacity. All registrants are asked to 

arrive at the CMS (Central Building) no 

later than 20 minutes before the 

scheduled starting time of each meeting 

session they wish to attend. 

IV. Security Information 

Since this meeting will be held in a 

Federal government building, Federal 

security measures are applicable. As 

noted above, in planning your arrival 

time, we recommend allowing 

additional time to clear security. All 

vehicles will be inspected inside and 

out at the entrance to the grounds. In 

order to gain access to the building, 

participants must bring a governmentissued photo identification (driver’s 

license, passport, etc.) and a copy of 

your registration information for the 

meeting. Access may be denied to 

persons without proper identification. 

All persons entering the building 

must pass through a metal detector. In 

addition, all items brought to CMS, 

whether personal or for the purpose of 

demonstration or to support a 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for 

demonstration or to support a 

presentation. 

Authority: Section 945 of the Medicare 

Prescription Drug, Improvement, and 

Modernization Act of 2003 (MMA). 

(Catalog of Federal Domestic Assistance 

Program No. 93.773, Medicare—Hospital 

Insurance; and Program No. 93.774, 

Medicare—Supplementary Medical 

Insurance Program) 

Dated: September 13, 2005. 

Mark B. McClellan, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 05–18925 Filed 9–22–05; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–3159–N] 

Medicare Program; Meeting of the 

Medicare Coverage Advisory 

Committee—November 29, 2005 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces a 

public meeting of the Medicare 

Coverage Advisory Committee (MCAC). 

The Committee provides advice and 

recommendations about whether 

scientific evidence is adequate to 

determine whether certain medical 

items and services are reasonable and 

necessary under the Medicare statute. 

This meeting concerns the treatments 

for age-related macular degeneration. 

Notice of this meeting is given under the 

Federal Advisory Committee Act (5 

U.S.C. App. 2, section 10(a)). 

DATES: The public meeting will be held 

on Tuesday, November 29, 2005 from 

7:30 a.m. until 4:30 p.m. e.s.t. 

Deadlines: Deadline for Presentations 

and Comments: Written comments and 

presentations must be received by 

October 31, 2005, 5 p.m., e.s.t. 

Deadline for Registration to Attend 

Meeting: For security reasons, 

individuals wishing to attend this 

meeting must register by close of 

business on November 22, 2005. 

Special Accommodations: Persons 

attending the meeting who are hearing 

or visually impaired, or have a 

condition that requires special 

assistance or accommodations, are 

asked to notify the Executive Secretary 

by November 22, 2005 (see FOR FURTHER

INFORMATION CONTACT). 

ADDRESSES: The meeting will be held in 

the main auditorium of the Centers for 

Medicare & Medicaid Services, 7500 

Security Blvd., Baltimore, MD 21244. 

FOR FURTHER INFORMATION CONTACT: 

Michelle Atkinson, Executive Secretary, 

by telephone at 410–786–2881 or by 

e-mail at 

Michelle.Atkinson@cms.hhs.gov. 

Web Site: You may access up-to-date 

information on this meeting at http:// 

www.cms.hhs.gov/mcac/ 

default.asp#meetings. 

Presentations And Comments: 

Interested persons can present data, 

information, or views orally or in 

writing on issues pending before the 

Committee. Please submit written 

comments to Michelle Atkinson, by 

e-mail at 

Michelle.Atkinson@cms.hhs.gov, or by 

mail to the Executive Secretary for 

MCAC, Coverage and Analysis Group, 

Office of Clinical Standards and 

Quality, Centers for Medicare & 

Medicaid Services, 7500 Security 

Boulevard, Mail Stop C1–09–06, 

Baltimore, MD 21244. 

SUPPLEMENTARY INFORMATION: 

I. Background 

On December 14, 1998, we published 

a notice in the Federal Register (63 FR 

68780) to describe the Medicare 

55906 Federal Register / Vol. 70, No. 184 / Friday, September 23, 2005 / Notices 

Coverage Advisory Committee (MCAC), 

which provides advice and 

recommendations to us about clinical 

issues. This notice announces a public 

meeting of the Committee. 

Meeting Topic: The Committee will 

discuss evidence and hear presentations 

and public comments regarding 

therapies and outcome measures for agerelated macular degeneration. 

Background information about this 

topic, including panel materials, is 

available on the Internet at http:// 

www.cms.hhs.gov/coverage/. 

II. Procedure 

This meeting is open to the public. 

The Committee will hear oral 

presentations from the public for 

approximately 45 minutes. The 

Committee can limit the number and 

duration of oral presentations to the 

time available. If you wish to make 

formal presentations, you must notify 

the Executive Secretary named in the 

FOR FURTHER INFORMATION CONTACT

section and submit the following by the 

Deadline for Presentations and 

Comments date listed in the DATES

section of this notice: a brief statement 

of the general nature of the evidence or 

arguments you wish to present, the 

names and addresses of proposed 

participants, and a written copy of your 

presentation. Your presentation should 

consider the questions we have posed to 

the Committee and focus on the issues 

specific to the topic. The questions will 

be available on our Web site at http:// 

www.cms.hhs.gov/mcac/default.asp 

meetings. We require that you declare at 

the meeting whether or not you have 

any financial involvement with 

manufacturers of any items or services 

being discussed (or with their 

competitors). 

After the public and CMS 

presentations, the Committee will 

deliberate openly on the topic. 

Interested persons may observe the 

deliberations, but the Committee will 

not hear further comments during this 

time except at the request of the 

chairperson. The Committee will also 

allow a 15 minute unscheduled open 

public session for any attendee to 

address issues specific to the topic. At 

the conclusion of the day, the members 

will vote, and the Committee will make 

its recommendation. 

III. Registration Instructions 

The Coverage and Analysis Group is 

coordinating meeting registration. While 

there is no registration fee, individuals 

must register to attend. You may register 

by contacting Maria Ellis at 410–786–

0309, mailing address: Coverage and 

Analysis Group, OCSQ; Centers for 

Medicare & Medicaid Services; 7500 

Security Blvd, Mailstop: C1–09–06; 

Baltimore, MD 21244, or by e-mail at 

Maria.Ellis@cms.hhs.gov. Please provide 

your name, address, organization, 

telephone and fax number, and e-mail 

address. 

You will receive a registration 

confirmation with instructions for your 

arrival at the CMS complex. You will be 

notified if the seating capacity has been 

reached. 

This meeting is located on Federal 

property; therefore, for security reasons, 

any individuals wishing to attend this 

meeting must register by close of 

business on November 22, 2005. 

IV. Security, Building, and Parking 

Guidelines 

This meeting will be held in a Federal 

government building; therefore, Federal 

security measures are applicable. In 

planning your arrival time, we 

recommend allowing additional time to 

clear security. 

In order to gain access to the building 

and grounds, individuals must present 

photographic identification to the 

Federal Protective Service or Guard 

Service personnel before being allowed 

entrance. 

Security measures also include 

inspection of vehicles, inside and out, at 

the entrance to the grounds. In addition, 

all individuals entering the building 

must pass through a metal detector. All 

items brought to CMS, whether personal 

or for the purpose of demonstration or 

to support a demonstration, are subject 

to inspection. We cannot assume 

responsibility for coordinating the 

receipt, transfer, transport, storage, setup, safety, or timely arrival of any 

personal belongings or items used for 

demonstration or to support a 

demonstration. 

Parking permits and instructions will 

be issued upon arrival. 

Note: Individuals who are not registered in 

advance will not be permitted to enter the 

building and will be unable to attend the 

meeting. The public may not enter the 

building earlier than 30 to 45 minutes prior 

to the convening of the meeting. 

All visitors must be escorted in areas 

other than the lower and first floor 

levels in the Central Building. 

Authority: 5 U.S.C. App. 2, section 10(a). 

(Catalog of Federal Domestic Assistance 

Program No. 93.774, Medicare—

Supplementary Medical Insurance Program) 

Dated: July 21, 2005. 

Barry M. Straube, 

Acting Chief Medical Officer and Acting 

Director, Office of Clinical Standards and 

Quality, Centers for Medicare & Medicaid 

Services. 

[FR Doc. 05–18924 Filed 9–22–05; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Improper Payments Information 

Survey for the TANF Program. 

OMB No.: New Collection. 

Description: This survey for the 

Temporary Assistance for Needy 

Families (TANF) program will request 

that States voluntarily provide 

information including how they define 

improper payments in their State, the 

process used to identify such payments 

and what actions are taken in the State 

to reduce or eliminate improper 

payments. HHS/ACF intends to 

establish a repository for the State 

submissions, which will be available to 

all States for viewing on an HHS/ACF 

website. This website will provide 

information that will help States 

improve their program integrity systems 

so that improper payments in the TANF 

program can be reduced. 

Respondents: The 50 States of the 

United States, the District of Columbia, 

and the Territories of Guam, Puerto Rico 

and the Virgin Islands 

ANNUAL BURDEN ESTIMATES

Instrument Number of respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

Improper Payments Information Survey for the TANF Program ..................... 54 1 24 1,296